Abbott India Ltd
About
Abbott India Limited, a subsidiary of Abbott Laboratories, manufactures and distributes products in diagnostics, medical devices and branded generic pharmaceuticals. The company’s main areas of focus are women's health, gastroenterology, cardiology, metabolic disorders and primary care. Abbott India spans the entire value chain and operates with the support of over 14,000 employees across its manufacturing facilities in Goa and Himachal Pradesh and its head office in Mumbai. The company’s branded generic pharmaceuticals are available in 500,000 pharmacies nationwide under 400 product lines. Beyond developing healthcare products, Abbott India also launched the Knowledge Genie e-learning programmes to ensure that medical professionals are kept updated about advancements in the industry.
Featured In Fortune India Ranking
Financial Data 2024
Fortune India Coverage
Financial Data
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 6116 11.9% | 5467 8.5% | 5038 12.1% | 4495 8.4% | 4146 9.3% | 3794 7.9% | 3518 14.9% | 3062 15.5% | 2650 11.4% | 2378 -1.2% | 2406 41.9% | 1695 7.1% | 1584 44.2% | 1098 31.6% | 835 15.2% | 725 - |
| Net Operating Income (INR Cr) | 5875 9.22% | 5379 9.05% | 4933 14.44% | 4310 5.30% | 4093 11.27% | 3679 11.52% | 3299 13.64% | 2903 11.02% | 2615 14.20% | 2289 0.59% | 2276 37.71% | 1653 10.90% | 1490 43.72% | 1037 30.50% | 795 14.22% | 696 11.76% |
| Profit (INR Cr) | 1201 26.5% | 949 18.9% | 799 15.6% | 691 16.5% | 593 31.7% | 450 12.2% | 401 45.0% | 277 8.4% | 255 11.5% | 229 15.4% | 198 37.2% | 145 20.2% | 120 97.6% | 61 -21.4% | 78 23.3% | 63 - |
| Assets (INR Cr) | 3897 14.8% | 3395 10.8% | 3064 7.7% | 2844 5.7% | 2691 29.2% | 2084 19.2% | 1748 21.9% | 1434 16.2% | 1234 26.4% | 977 17.2% | 833 23.2% | 676 21.0% | 559 83.0% | 305 12.5% | 272 22.3% | 222 - |
| Net Worth (INR Cr) | 3699 16.0% | 3189 13.1% | 2820 8.4% | 2602 7.0% | 2432 21.1% | 2009 18.7% | 1693 22.1% | 1387 16.0% | 1196 27.5% | 938 19.0% | 788 21.8% | 647 18.9% | 544 78.2% | 305 12.5% | 272 22.7% | 221 -4.2% |
| Employee Cost (INR Cr) | 577 2.3% | 564 -2.7% | 579 17.6% | 493 3.5% | 476 9.3% | 436 10.6% | 394 14.0% | 345 1.2% | 341 11.7% | 305 1.9% | 300 45.4% | 206 23.2% | 167 54.8% | 108 81.2% | 60 30.4% | 46 - |
| Interest Cost (INR Cr) | 12 | 16 | 19 | 18 | 9 | 2 | 4 | 2 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash & Bank Balance (INR Cr) | 2134 | 1937 | 2749 | 2409 | 2197 | 1684 | 1031 | 1091 | 839 | 644 | 463 | 323 | 259 | 189 | 176 | 164 |
| Total Debt (INR Cr) | 83 | 113 | 152 | 153 | 175 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Key Financial Ratios
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 19.6% | 17.4% | 15.9% | 15.4% | 14.3% | 11.9% | 11.4% | 9.0% | 9.6% | 9.6% | 8.3% | 8.5% | 7.6% | 5.6% | 9.3% | 8.7% |
| Profit As % Of Assets | 30.8% | 28.0% | 26.1% | 24.3% | 22.0% | 21.6% | 23.0% | 19.3% | 20.7% | 23.4% | 23.8% | 21.4% | 21.5% | 20.0% | 28.5% | 28.3% |
| Profit As % Of Networth | 32.5% | 29.8% | 28.3% | 26.5% | 24.4% | 22.4% | 23.7% | 20.0% | 21.4% | 24.4% | 25.2% | 22.4% | 22.1% | 20.0% | 28.5% | 28.4% |
| Interest Cost to EBITDA % | 0.9% | 1.3% | 1.8% | 2.0% | 1.1% | 0.4% | 0.7% | 0.5% | 0.7% | 0.2% | 0.0% | 0.0% | 0.0% | 0.1% | 0.2% | 0.0% |
| Debt to Equity Ratio | 0.02 | 0.04 | 0.05 | 0.06 | 0.07 | - | - | - | - | - | - | - | - | - | - | 0.00 |
| RONW | 34.9% | 31.6% | 29.5% | 27.4% | 26.7% | 24.3% | 26.1% | 21.4% | 23.9% | 26.5% | 22.1% | 24.3% | 28.3% | 19.5% | 31.5% | 27.8% |
| ROCE | 44.7% | 39.9% | 37.2% | 34.1% | 34.0% | 36.6% | 39.3% | 32.9% | 36.2% | 38.1% | 31.2% | 34.8% | 41.7% | 30.1% | 47.6% | 41.6% |